Microfluidics Revenue and Competitors
Estimated Revenue & Valuation
- Microfluidics's estimated annual revenue is currently $9.7M per year.
- Microfluidics's estimated revenue per employee is $268,280
- Microfluidics's total funding is $1.7M.
- Microfluidics's current valuation is $12.9B. (June 2019)
Employee Data
- Microfluidics has 36 Employees.
- Microfluidics grew their employee count by -5% last year.
Microfluidics's People
Name | Title | Email/Phone |
---|
Microfluidics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.7M | 36 | -5% | $1.7M | $12.9B |
What Is Microfluidics?
Microfluidics International Corporation designs, manufactures and distributes proprietary high performance Microfluidizer® materials processing and formulation equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care and food industries. Microfluidics applies its more than 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid particles available, and has provided manufacturing systems for nanoparticle products for more than 15 years.
keywords:Manufacturing$1.7M
Total Funding
36
Number of Employees
$9.7M
Revenue (est)
-5%
Employee Growth %
$12.9B
Valuation
N/A
Accelerator
Microfluidics News
Global Biochips (Microarrays/Microfluidics) Market 2022 Business Standards and Competition Landscape 2028 Abbott, Agilent, PerkinElmer,...
USD 45+ Bn Global Microfluidics Market is Expected to Grow at a CAGR of over 15.90% During 2022-2028 | Vantage Market Research. April 22, 2022...
Microfluidics has a wide variety of applications within the life sciences industry including cell biology, particle analysis, and biosensors.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.6M | 36 | -3% | N/A |
#2 | N/A | 37 | 12% | N/A |
#3 | $6.1M | 38 | 15% | $24.7M |
#4 | $7.1M | 39 | 0% | N/A |
#5 | $10.6M | 41 | 8% | N/A |